Danh mục thuốc thiết yếu của Tổ chức y tế thế giới
Số trang: 45
Loại file: pdf
Dung lượng: 431.51 KB
Lượt xem: 10
Lượt tải: 0
Xem trước 5 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
The core list presents a list of minimum medicine needs for a basic health‐care system, listing the mostefficacious, safe and cost‐effective medicines for priority conditions. Priority conditions are selected on thebasis of current and estimated future public health relevance, and potential for safe and cost‐effectivetreatment.The complementary list presents essential medicines for priority diseases, for which specialized diagnosticor monitoring facilities, and/or specialist medical care, and/or specialist training are needed. In case of doubtmedicines may also be listed as complementary on the basis of consistent higher costs or less attractive costeffectivenessin a variety of settings....
Nội dung trích xuất từ tài liệu:
Danh mục thuốc thiết yếu của Tổ chức y tế thế giới WHOModelList of EssentialMedicines 17thlist (March2011) Statusofthisdocument ThisisareprintofthetextontheWHOMedicineswebsite http://www.who.int/medicines/publications/essentialmedicines/en/index.html Thepublishedmaterialisbeingdistributedwithoutwarrantyofanykind,eitherexpressedorimplied.The responsibilityfortheinterpretationanduseofthemateriallieswiththereader.InnoeventshalltheWorldHealth Organizationbeliablefordamagesarisingfromitsuse.17theditionEssentialMedicinesWHOModelList(March2011)ExplanatoryNotesThecorelistpresentsalistofminimummedicineneedsforabasichealth‐caresystem,listingthemostefficacious,safeandcost‐effectivemedicinesforpriorityconditions.Priorityconditionsareselectedonthebasisofcurrentandestimatedfuturepublichealthrelevance,andpotentialforsafeandcost‐effectivetreatment.Thecomplementarylistpresentsessentialmedicinesforprioritydiseases,forwhichspecializeddiagnosticormonitoringfacilities,and/orspecialistmedicalcare,and/orspecialisttrainingareneeded.Incaseofdoubtmedicinesmayalsobelistedascomplementaryonthebasisofconsistenthighercostsorlessattractivecost‐effectivenessinavarietyofsettings.Thesquareboxsymbol( )isprimarilyintendedtoindicatesimilarclinicalperformancewithinapharmacologicalclass.Thelistedmedicineshouldbetheexampleoftheclassforwhichthereisthebestevidenceforeffectivenessandsafety.Insomecases,thismaybethefirstmedicinethatislicensedformarketing;inotherinstances,subsequentlylicensedcompoundsmaybesaferormoreeffective.Wherethereisnodifferenceintermsofefficacyandsafetydata,thelistedmedicineshouldbetheonethatisgenerallyavailableatthelowestprice,basedoninternationaldrugpriceinformationsources.Notallsquareboxesareapplicabletomedicineselectionforchildren—seethesecondEMLcfordetails.TherapeuticequivalenceisonlyindicatedonthebasisofreviewsofefficacyandsafetyandwhenconsistentwithWHOclinicalguidelines.Nationallistsshouldnotuseasimilarsymbolandshouldbespecificintheirfinalselection,whichwoulddependonlocalavailabilityandprice.The a symbolindicatesthatthereisanageorweightrestrictiononuseofthemedicine;detailsforeachmedicinecanbefoundinTable1.Wherethe[c]symbolisplacednexttothecomplementarylistitsignifiesthatthemedicine(s)require(s)specialistdiagnosticormonitoringfacilities,and/orspecialistmedicalcare,and/orspecialisttrainingfortheiruseinchildren.Wherethe[c]symbolisplacednexttoanindividualmedicineorstrengthofmedicineitsignifiesthatthereisaspecificindicationforrestrictingitsusetochildren.ThepresenceofanentryontheEssentialMedicinesListcarriesnoassuranceastopharmaceuticalquality.Itistheresponsibilityoftherelevantnationalorregionaldrugregulatoryauthoritytoensurethateachproductisofappropriatepharmaceuticalquality(includingstability)andthatwhenrelevant,differentproductsareinterchangeable.ForrecommendationsandadviceconcerningallaspectsofthequalityassuranceofmedicinesseetheWHOMedicineswebsitehttp://www.who.int/medicines/areas/quality_assurance/en/index.html.Medicinesanddosageformsarelistedinalphabeticalorderwithineachsectionandthereisnoimplicationofpreferenceforoneformoveranother.Standardtreatmentguidelinesshouldbeconsultedforinformationonappropriatedosageforms.ThemaintermsusedfordosageformsintheEssentialMedicinesListcanbefoundinAnnex1.DefinitionsofmanyofthesetermsandpharmaceuticalqualityrequirementsapplicabletothedifferentcategoriesarepublishedinthecurrenteditionofTheInternationalPharmacopoeiahttp://www.who.int/medicines/publications/pharmacopoeia/en/index.html.EssentialMedicines 17theditionWHOModelList 1. ANAESTHETICS 1.1 General anaesthetics and oxygen 1.1.1 Inhalati ...
Nội dung trích xuất từ tài liệu:
Danh mục thuốc thiết yếu của Tổ chức y tế thế giới WHOModelList of EssentialMedicines 17thlist (March2011) Statusofthisdocument ThisisareprintofthetextontheWHOMedicineswebsite http://www.who.int/medicines/publications/essentialmedicines/en/index.html Thepublishedmaterialisbeingdistributedwithoutwarrantyofanykind,eitherexpressedorimplied.The responsibilityfortheinterpretationanduseofthemateriallieswiththereader.InnoeventshalltheWorldHealth Organizationbeliablefordamagesarisingfromitsuse.17theditionEssentialMedicinesWHOModelList(March2011)ExplanatoryNotesThecorelistpresentsalistofminimummedicineneedsforabasichealth‐caresystem,listingthemostefficacious,safeandcost‐effectivemedicinesforpriorityconditions.Priorityconditionsareselectedonthebasisofcurrentandestimatedfuturepublichealthrelevance,andpotentialforsafeandcost‐effectivetreatment.Thecomplementarylistpresentsessentialmedicinesforprioritydiseases,forwhichspecializeddiagnosticormonitoringfacilities,and/orspecialistmedicalcare,and/orspecialisttrainingareneeded.Incaseofdoubtmedicinesmayalsobelistedascomplementaryonthebasisofconsistenthighercostsorlessattractivecost‐effectivenessinavarietyofsettings.Thesquareboxsymbol( )isprimarilyintendedtoindicatesimilarclinicalperformancewithinapharmacologicalclass.Thelistedmedicineshouldbetheexampleoftheclassforwhichthereisthebestevidenceforeffectivenessandsafety.Insomecases,thismaybethefirstmedicinethatislicensedformarketing;inotherinstances,subsequentlylicensedcompoundsmaybesaferormoreeffective.Wherethereisnodifferenceintermsofefficacyandsafetydata,thelistedmedicineshouldbetheonethatisgenerallyavailableatthelowestprice,basedoninternationaldrugpriceinformationsources.Notallsquareboxesareapplicabletomedicineselectionforchildren—seethesecondEMLcfordetails.TherapeuticequivalenceisonlyindicatedonthebasisofreviewsofefficacyandsafetyandwhenconsistentwithWHOclinicalguidelines.Nationallistsshouldnotuseasimilarsymbolandshouldbespecificintheirfinalselection,whichwoulddependonlocalavailabilityandprice.The a symbolindicatesthatthereisanageorweightrestrictiononuseofthemedicine;detailsforeachmedicinecanbefoundinTable1.Wherethe[c]symbolisplacednexttothecomplementarylistitsignifiesthatthemedicine(s)require(s)specialistdiagnosticormonitoringfacilities,and/orspecialistmedicalcare,and/orspecialisttrainingfortheiruseinchildren.Wherethe[c]symbolisplacednexttoanindividualmedicineorstrengthofmedicineitsignifiesthatthereisaspecificindicationforrestrictingitsusetochildren.ThepresenceofanentryontheEssentialMedicinesListcarriesnoassuranceastopharmaceuticalquality.Itistheresponsibilityoftherelevantnationalorregionaldrugregulatoryauthoritytoensurethateachproductisofappropriatepharmaceuticalquality(includingstability)andthatwhenrelevant,differentproductsareinterchangeable.ForrecommendationsandadviceconcerningallaspectsofthequalityassuranceofmedicinesseetheWHOMedicineswebsitehttp://www.who.int/medicines/areas/quality_assurance/en/index.html.Medicinesanddosageformsarelistedinalphabeticalorderwithineachsectionandthereisnoimplicationofpreferenceforoneformoveranother.Standardtreatmentguidelinesshouldbeconsultedforinformationonappropriatedosageforms.ThemaintermsusedfordosageformsintheEssentialMedicinesListcanbefoundinAnnex1.DefinitionsofmanyofthesetermsandpharmaceuticalqualityrequirementsapplicabletothedifferentcategoriesarepublishedinthecurrenteditionofTheInternationalPharmacopoeiahttp://www.who.int/medicines/publications/pharmacopoeia/en/index.html.EssentialMedicines 17theditionWHOModelList 1. ANAESTHETICS 1.1 General anaesthetics and oxygen 1.1.1 Inhalati ...
Gợi ý tài liệu liên quan:
-
Thực trạng kiến thức phòng chống tai nạn thương tích của người dân trên địa bàn Hà Nội năm 2018
7 trang 31 0 0 -
Bài giảng Quản lý y tế - Chương 1: Giới thiệu về hệ thống y tế
46 trang 24 0 0 -
Phương pháp Tổ chức và quản lý y tế: Phần 1
109 trang 23 0 0 -
Bài 1: Các khái niệm về sức khỏe và bệnh tật - ThS.BS. Nguyễn thế Dũng
4 trang 17 0 0 -
6 trang 15 0 0
-
8 trang 13 0 0
-
8 trang 13 0 0
-
Bài giảng Tổ chức và quản lý hệ thống y tế - Chương 1: Giới thiệu về hệ thống y tế
55 trang 13 0 0 -
Danh mục các từ đồng nghĩa - High Frequent Words in Reading Comprehension of TF tests
168 trang 12 0 0 -
163 trang 11 0 0